European Archives - Page 50 of 1556 - European Medical Journal

Aficamten Improves Hypertrophic Cardiomyopathy Exercise Performance

New evidence suggests Aficamten improves exercise performance compared with Metoprolol in patients with obstructive hypertrophic cardiomyopathy.

Study Reveals Predictors of Severe Respiratory Disease in Children

Children hospitalised with acute respiratory tract infections were more likely to develop severe disease if they had multiple chronic conditions or required transfer from another hospital.

Treating Hearing Loss Lowers Dementia Risk in Epilepsy: EAN 2026

Treating Hearing Loss Lowers Dementia Risk in Epilepsy: EAN 2026

Research presented at EAN 2026 finds hearing aids may cut dementia risk in people with epilepsy and hearing loss, a benefit specific to that group.

Previous Norovirus Exposure May Shape Vaccine Responses

Immune imprinting from earlier norovirus infections may influence how older adults respond to vaccination, according to new research.

Paroxetine Targets Neurovascular-Immune Pathways in Rosacea

A proteomic study reveals how paroxetine may improve refractory rosacea by influencing neurovascular-immune pathways and identifying potential treatment biomarkers.

Lifetime Obesity Exposure Underestimated in Cancer Care

More than half of patients receiving systemic anticancer therapy had a history of lifetime obesity, far exceeding obesity rates at treatment initiation.

Eye Test Predicts Consciousness Recovery After Brain Injury: EAN 2026

Eye Test Predicts Consciousness Recovery After Brain Injury: EAN 2026

Research presented at EAN 2026 suggests a 13-second pupil test could predict recovery of consciousness in patients with severe acute brain injury.

Novel CAR-T Cell Targets Identified for AML

Researchers evaluated 63 AML associated antigens and identified 13 leading candidates that may help advance the development of CAR T cell therapy in AML.

Allergy and Immunology Misinformation Unchallenged on Social Media

Allergy and immunology misinformation is rife on social media, often left unchallenged, new analysis has found.

IBD Unclassified Diagnosis Remains Stable Long Term

A long-term observational study found that most patients with IBD-U retained their diagnosis, while experiencing distinct treatment patterns and increased healthcare utilisation.